Is peak postoperative hsTnT associated with 30-day mortality in patients undergoing noncardiac surgery?
Postoperative hsTnT elevation is a prognostic marker for 30-day mortality in noncardiac surgery patients, regardless of ischemic features.
Among patients undergoing noncardiac surgery, peak postoperative hsTnT during the first 3 days after surgery was significantly associated with 30-day mortality. Elevated postoperative hsTnT without an ischemic feature was also associated with 30-day mortality.
Devereaux et al. (Tue,) studied this question.